Abstract -Calbindin-D 9k (CaBP-9k), a cytosolic calcium-binding protein, is expressed in a variety of tissues, i.e., the duodenum, uterus, placenta, kidney and pituitary gland. Duodenal CaBP-9k is involved in intestinal calcium absorption, and is regulated at transcriptional and post-transcriptional levels by 1,25-dihydroxyvitamin D3, the hormonal form of vitamin D, and glucocorticoids (GCs). Uterine CaBP-9k has been implicated in the regulation of myometrial action(s) through modulation of intracellular calcium, and steroid hormones appear to be the main regulators in its uterine and placental regulation. Because phenotypes of CaBP-9k-null mice appear to be normal, other calcium-transporter genes may compensate for its gene deletion and physiological function in knockout mice. Previous studies indicate that CaBP-9k may be controlled in a tissue-specific fashion. In this review, we summarize the current information on calcium homeostasis related to CaBP-9k gene regulation by GCs, vitamin D and its receptors, and its molecular regulatory mechanism. In addition, we present related data from our current research.
proteins. The movement of luminal calcium across microvillar membrane into enterocytes appears to be regulated by two epithelial calcium channels, transient receptor potential vanilloid 5 and 6 (TRPV6 and TRPV5) (Kim et al., 2006; Kim et al., 2009) .
Calbindin-D 9k (CaBP-9k), a calcium-binding protein, has been implicated in active calcium absorption in various tissues as an intracellular calcium ion-binding protein Lambers et al., 2006; Choi and Jeung 2008) . Apical calcium influx is rapidly buffered by this protein, which then shuttles calcium ions from the apical to the basolateral membrane, where Na ＋ /Ca 2＋ exchanger (NCX1) and plasma membrane Ca 2＋ -ATPase 1b (PMCA1b) account for calcium ion extrusion as seen in Fig. 1 (Wasserman and Fullmer, 1995; Peng et al., 2003; van Abel et al., 2005; Lee et al., 2007) . CaBP-9k knockout (KO) mice normally survive without any abnormality, apparently supported by calcium processing genes acting in a compensatory manner (Lee et al., 2007) . In the previous studies, duodenal CaBP-9k was up-regulated by 1,25-dihydroxyvitamin D 3 , and down-regulated by gluco- Fig. 1 . Calcium transport system in the duodenum and kidney. The dynamic calcium transport pathways may be differentially controlled by various calcium transporter genes in the duodenum (A) and kidney (B). TRPV6 is known as epithelial calcium channel 2 (EcaC2) and calcium transporter 1 (CaT1), while TRPV5 is also called EcaC1 and CaT2. corticoids (GCs) (Darwish and DeLuca 1992; Barley et al., 1999; Lee et al., 2006) , indicating that vitamin D and GCs are potential regulators in the control of the CaBP-9k gene in the small intestine. The KO mice of CaBP-9k gene showed normal serum concentrations of calcium and exhibited no abnormal phenotype (Gkika et al., 2006; Akhter et al., 2007; Lee et al., 2007) , suggesting that the function(s) of this gene in the duodenum and kidney may be compensated by the increased expression of other active calcium transport proteins (Kutuzova et al., 2006; Lee et al., 2007) .
GLUCOCORTICOIDS AND THEIR RECEPTORS IN THE REGULATION OF CaBP-9k
GCs have been used in the treatment of various diseases, e.g., asthma, rheumatoid arthritis and atopic dermatitis. The favorable efficacy of GCs as an anti-inflammatory agent is offset by the occurrence of side effects, including osteoporosis, hypothalamus-pituitary-adrenal axis suppression, cataract formation, skin thinning, growth retardation and bruising (McLaughlin et al., 2002) . Of these side effects, potentially the most serious and debilitating is the development of glucocorticoid-induced osteoporosis (GIO) (Patschan et al., 2001) . Potential mechanism(s) in GC-induced GIO have been suggested (Schacke et al., 2002) . For instance, GCs inhibit bone formation by suppressing the proliferation and activity of osteoblasts and osteocytes, and reduce the population of bone cells by increasing apoptosis (Silvestrini et al., 2000) . GCs decrease absorption of gastrointestinal calcium ions and increase excretion of urinary calcium ions. A number of critical mediators in bone homeostasis, i.e., sex hormones, growth hormone, insulin-like factor-1, and TGF-beta, seem to be also suppressed by GCs.
Although studies of GC-induced effects on bone cells have been carried out over the last several decades, the exact GC-effects on intestinal calcium transport and renal calcium elimination have not clearly been shown. Intestinal calcium absorption decreases in the presence of long-term and high doses of GCs in humans and rats (Lukert and Raisz, 1990) . Decreases in active transcellular transport and in normal brush-border vesicle uptake of calcium and reduced calcium-binding proteins in the intestine are considered as cellular mechanisms resulting in diminished intestinal calcium absorption (Shultz et al., 1982) . In parallel, GCs have been demonstrated to increase renal calcium elimination and epithelial calcium transport capacity Role of Calbindin-D9k and Vitamin D 127 (Nijenhuis et al., 2004) . Long-term treatment with GCs resulted in marked hypercalciuria and fasting urine calcium excretion (Cosman et al., 1994) . This GC-induced imbalance of calcium promotes secondary hyperparathyroidism, and the increased parathyroid hormones (PTHs) cause bone re-absorption due to an increase in osteoclast activity (Ziegler and Kasperk, 1998) , which eventually results in osteoporosis.
In our previous study, we showed that duodenal CaBP-9k mRNA and protein levels were significantly decreased by dexamethasone (Dex) treatment, whereas renal CaBP-9k mRNA and protein levels were unchanged . Huybers et al. reported that daily prednisolone treatment for 7 days reduced duodenal TRPV6 (Huybers et al., 2007) . The expression of duodenal TRPV6 declined in Dex-treated mice, and its level in CaBP-9k and CaBP-28k KO mice was up-regulated when compared to that of WT mice Lee et al., 2007; Kim et al., 2009) . With regard to duodenal gene regulation by Dex, these results imply that the decrease in duodenal CaBP-9k and TRPV6 gene expression may contribute to the pathogenesis of GIO (Kim et al., 2009 ). In addition, our results suggest that a compensatory mechanism of CaBP-9k and CaBP-28k deficiency appears to function in the KO mice; but GCs down-regulate duodenal CaBP-9k and TRPV6 transcription in parallel with the previous studies Huybers et al., 2007) . Because duodenal active calcium-processing genes were considered to be the major target for GC-induced gene suppression, we further clarified any alteration in the duodenal protein levels and their spatial expression. However, there were no differences in the expression patterns of duodenal TRPV6, CaBP-9k, NCX1 or PMCA1b after Dex treatment (Kim et al., 2009) . Taken together, these results suggest that duodenal CaBP-9k and TRPV6 in the active calcium transport system may play key roles in the disruption of calcium homeostasis by chronic GC treatment, and the absence of CaBP-9k and CaBP-28k can be compensated by other active calcium transport components.
GCs and the glucocorticoid receptor (GR) are known to be essential factors in cellular differentiation and maintenance of mineral absorption (Beaulieu and Calvert, 1985; Sheppard et al., 1999) . The previous reports described GR expression and distribution in the duodenum and kidney (Merot et al., 1989; Farman et al., 1991; Lee et al., 2006) . In our previous study, we further employed Dex to elucidate the role of GR in the regulation of calcium-processing genes, and its differential expression in CaBP-9k KO mice (Kim et al., 2009) . Interestingly, the expression of duodenal and renal GR was significantly down-regulated by Dex in wild-type (WT) mice. However, GR mRNA levels in the duodenum and kidney were unaltered in CaBP-9k or CaBP-28k KO mice. Therefore, it can be concluded that the number of GRs may not cause the induction of compensatory genes in these KO mice Lee et al., 2007; Kim et al., 2009) . Serum corticosterone levels were examined as a potential candidate for the compensatory gene induction and differential effect of Dex treatment on the expression of calcium processing genes in the KO mice. The serum corticosterone levels in these mouse models revealed surprising information, indicating that the corticosterone levels in CaBP-9k and -28k KO mice were significantly lower than those of WT mice (Kim et al., 2009) . The gene induction in CaBP-9k and CaBP-28k KO mice may be the result of low serum corticosterone levels. This conclusion is supported by previous reports demonstrating that synthetic GCs down-regulated duodenal CaBP-9k and TRPV6 expression Huybers et al., 2007) . Serum corticosterones in all animals were significantly reduced after Dex treatment. Dex provides negative feedback to the pituitary to suppress the secretion of adrenocorticotropic hormone, resulting in the suppression of serum corticosterone levels. Therefore, these results imply that these mice may be affected by exogenous Dex treatment (Cole et al., 2000; McGowan et al., 2000) .
VITAMIN D AND ITS RECEPTORS IN THE REGULATION OF CaBP-9k
Intestinal CaBP-9k is involved in intestinal calcium absorption and is regulated at the transcriptional and posttranscriptional level by 1,25-dihydroxyvitamin D3 in rodents (Roche et al., 1986; Wasserman and Fullmer, 1989; Darwish and DeLuca, 1992) . In addition, the expression of duodenal CaBP-9k has been shown to be controlled by 1,25-dihydroxycholecalciferol in humans . Furthermore, vitamin D regulation of this gene may also be important in reproductive tissues (Kwiecinksi et al., 1989; Uhland et al., 1992) . Although the intestinal level of CaBP-9k is clearly vitamin D-controlled, its placental and uterine levels do not respond to vitamin D depletion. Therefore, CaBP-9k does not seem to be under the control of vitamin D despite the presence of vitamin D receptors in the uterus. Rather, uterine CaBP-9k appears to be controlled by sex hormones (Darwish et al., 1991; L'Horset et al., 1994) . Renal CaBP-9k is expressed at distal convoluted tubule and appears to facilitate calcium re-absorption in this tissue (Peng et al., 2000) .
The biological actions of the active form of vitamin D 3 and its synthetic analogs are mediated by the nuclear vitamin D receptor (VDR) (Panda et al., 2004; Nagpal et al., 2005) . VDR is a ligand-dependent transcription factor belonging to the superfamily of steroid/thyroid hormone receptors, and has been associated with calcemic activities, including calcium and phosphorus homeostasis, and maintenance of bone content (Nagpal et al., 2005) . In VDR KO mice, the expression levels of CaBP-9k, TRPV6 and TRPV5 were considerably reduced as compared to those in WT littermates, whereas the expression levels of CaBP-28k, NCX1 and PMCA1b were not altered (Li and Christakos, 1991; Chailley-Heu et al., 2001; Li et al., 2001; Van Cromphaut et al., 2001) . Previously, we showed that Dex decreased duodenal VDR mRNA levels, suggesting that diminished levels of VDR mediate the down-regulation of duodenal CaBP-9k and TRPV6 (Kim et al., 2009) . Furthermore, VDR expression increased in CaBP-9k or CaBP-28k KO mice. Conversely, renal VDR mRNA levels remained unchanged in all groups, with the exception of Dex-treated CaBP-9k KO mice. This result may suggest that renal VDR sensitivity in CaBP-9k KO mice can be increased by GCs (Kim et al., 2009 ). Previously, it was shown that a 1-day treatment with Dex significantly increased duodenal and renal VDR mRNA levels, while 5-day Dex treatment diminished duodenal VDR and restored renal VDR expression to the level observed in vehicle only treated animals (Unpublished data). Taken together, these results imply that Dex regulates VDR transcription, and that this may directly regulate the expression of duodenal CaBP-9k and TRPV6 through a GC-mediated pathway (Kim et al., 2009) . The regulation of CaBP-9k in gastrointestinal tissues is not completely understood. The vitamin D-responsive DNA element is found in the CaBP-9k gene promoter region, which has been shown to regulate the expression of CaBP-9k in the intestine (Delorme et al., 1983) . CaBP-9k is actively expressed in enterocytes, which are the dominant epithelial cells in the duodenal mucosa ). CaBP-9k expression level decreases downstream from the duodenum and its levels are barely detectable in the distal ileum and large intestine. CaBP-9k is considered to be an important factor in calcium absorption and metabolism in the intestine. Although several studies examined the molecular regulatory mechanisms of active calcium-transport genes in regards to hypocalcemia, rickets and osteomalacia in VDR-null mice and 1α-hydroxylasedeficient mice, the exact mechanism remains unclear (Van Cromphaut et al., 2001; Zheng et al., 2004) . In our previous study, CaBP-9k and other calcium-transport proteins were thought to be the rate-limiting factors in active calcium transport; however, our CaBP-9k KO mice exhibit no abnormalities (Lee et al., 2007) . It is known that some KO animals present normal phenotypes due to compensatory gene induction (Wertheimer et al., 2001; Xu et al., 2004; Tanabe et al., 2005) . Thus, we hypothesized that these KO animals might have compensatory gene induction that can replace CaBP-9k, and that this compensatory regulation might help to elucidate the mechanisms of active calcium transport genes.
As mentioned above, hypocalcemia, rickets and osteomalacia of VDR-KO mice may be a result of reduced VDR gene expression. Li et al. demonstrated that renal CaBP-9k may take part in renal calcium re-absorption, and Van Chromphaut et al. suggested that TRPV6 and CaBP-9k appear to be involved in duodenal calcium absorption (Li et al., 2001; Van Cromphaut et al., 2001) . To understand the exact role(s) of CaBP-9k, we generated CaBP-9k-null mice. However, no abnormal phenotypes were observed, as was the case in the VDR-KO mice. In addition, CaBP9k-KO mice were phenotypically normal at birth and survived normally for at least one year.
PTH is secreted by the parathyroid gland, and acts principally to regulate calcium and phosphate metabolism by binding to its receptors (PTHRs), which are expressed in the kidney and bone (Juppner et al., 1991; Pausova et al., 1994) . PTHR is also widely expressed in the bone cells of osteoblast lineage, and in the kidney it is expressed in the glomerulus and at several sites along the nephron (Rouleau et al., 1988; McCuaig et al., 1995) . PTH regulates the conversion of 25-hydroxyvitamin D to the active metabolite 1,25(OH)2D3. PTH also activates dihydropyridine-sensitive channels, which mediate calcium entry (Bacskai and Friedman, 1990) . Microtubule-dependent exocytosis stimulated by PTH is required for the activation of calcium channels and calcium influx. In our study, we investigated whether there is cross-talk between PTHR and VDR in GC-mediated regulation of calcium-processing genes in CaBP KO mice. There was no distinct alteration in renal PTHR mRNA levels in Dex-treated animals compared to control, suggesting that CaBP gene deficiency and Dex treatment may not to be related to the transcription of PTHR (Kim et al., 2009 ).
CaBP-9k AND ITS COMPENSATORY MECHANISM IN THE KNOCKOUT MODELS
In spite of CaBP-9k depletion, CaBP-9k-null mice maintained normal serum calcium concentrations and showed no abnormal symptoms, suggesting that a normal diet satisfies the calcium requirements of CaBP-9k KO mice. To compare calcium homeostasis ability in both KO and WT mice, these mice were fed low-, normal-and high-calcium diets during the growth period from 3 to 10 weeks of age. Duodenal TRPV6 and CaBP-9k mRNA levels in WT mice increased inversely with the diet calcium concentration (Brown et al., 2005) . In the low-and normal-calcium-diet groups, TRPV6 transcript levels in WT mice were higher than those of KO mice; however, further studies are necessary to verify whether CaBP-9k directly regulates TRPV6 gene transcription or whether other factors are involved in. Although the levels of duodenal PMCA1b and NCX1 mRNAs fluctuated with dietary calcium levels, no significant differences between WT and KO mice were detected (Lee et al., 2007) . Duodenal PMCA1b mRNA levels in VDR KO mice were reduced by a low-calcium diet (Van Cromphaut et al., 2003) . However, no specific differences were found in our study, suggesting that duodenal calcium-transport genes may participate in calcium absorption in spite of CaBP-9k depletion (Lee et al., 2007) .
Calcium-transport genes are differentially expressed in an organ-specific manner depending on gender. Although duodenal TRPV6, CaBP-9k and NCX1 mRNAs were highly expressed in WT female mice fed a low-calcium diet, no induction of TRPV6 or NCX1 genes was detected in CaBP-9k-null mice (Lee et al., 2007) . In the kidney, all calcium transport genes were highly expressed in female mice. Renal TRPV6 was not significantly induced in WT male mice receiving a regular diet, but TRPV6 mRNA levels in female mice were increased. These distinct patterns in renal TRPV5, renal CaBP-28k, duodenal TRPV6 and duodenal CaBP-9k expressions imply that the response of calcium transport genes is more sensitive in females than in males (Lee et al., 2007) . The up-regulation of calcium-absorption genes is higher in female mice due to circulating sex steroid hormone levels (Song et al., 2003) ; however, gene expression in the kidney and duodenum was unaffected by estrous cycle in parallel with our unpublished data. A further study examining protein levels is needed to determine definitively whether there is gender specific compensatory change (Choi and Jeung, 2008) .
In the recent study, the role of TRPV6 and CaBP-9k on intestinal calcium absorption was examined in the KO mice of TRPV6, CaBP-9k and TRPV6/CaBP-9k, demonstrating that significant active intestinal calcium transport occurs in the absence of TRPV6 and calbindin-D9k in these null mutant mice and suggesting that TRPV6 and CaBP-9k may be not essential for vitamin D-induced active intestinal calcium transport (Benn et al., 2008) . On the other hand, the requirement of TRPV6 for vitamin D-dependent intestinal calcium absorption in vivo was examined in vitamin D-deficient TRPV6 null and WT mice (Kutuzova et al., 2008) . This previous study together with microarray results indicated that TRPV6 is not required for vitamin D-induced intestinal calcium absorption and may not carry out a significant role in this process. These results obtained from CaBP-9k null and other calcium transport mutant mice illustrated that exact molecular events in the intestinal calcium transport in response to the active form of vitamin D are warranted to be elucidated (Kutuzova et al., 2008) .
Uterine CaBP-9k regulated by endogenous and exogenous progesterone is strongly and uniformly induced in the luminal epithelium prior to implantation, but specifically decreases at the site of embryo attachment during implantation (Nie et al., 2000; Hong et al., 2003; Lee et al., 2003; Hong et al., 2004; Lee et al., 2004; Lee et al., 2005) . Furthermore, CaBP-28k is expressed in a pattern similar to CaBP-9k during early pregnancy (Luu et al., 2004) , and uterine CaBP-9k and -28k during early pregnancy have been thought to play a critical role in implantation (Nie et al., 2005) . The antisense oligonucleotides of CaBP-9k completely blocked embryo implantation in CaBP-28k-null mice with normal fertilization (Luu et al., 2004) . In the study, the numbers of corpora lutea and litter sizes of CaBP-9k-null mice were within the normal WT range. These observations imply that CaBP-9k may not be an essential factor for embryo implantation, or may be important but dispensable, and that CaBP-9k function can be compensated by the induction of other calcium-related genes such as CaBP-28k.
CONCLUDING REMARKS
Duodenal CaBP-9k may act as a gatekeeper in duodenal active calcium transport. The expression of this gene was up-regulated in both types of KO mice, and Dex directly affected duodenal VDR transcription, a treatment which may decrease TRPV6 and CaBP-9k levels in the duodenum of all genotypes. CaBP-9k should be considered as an important factor in active calcium transport; however, it can be compensated for by other calcium-transport genes that maintain normality in CaBP-9k-null mice, including intestinal TRPV6 and PMCA1b during pre-weaning, and renal TRPV6 and TRPV5 during growth and development. TRPV6 is known as epithelial calcium channel 2 (EcaC2) and calcium transporter 1 (CaT1), while TRPV5 is also called EcaC1 and CaT2. In addition, CaBP-9k may participate as a rate-limiting factor in duodenal and renal active calcium transport by interacting with TRPV6, TRPV5 and PMCA1b genes. Calcium-transport proteins play systematic, but complicated roles within a single cellular compartment, such that genetic inactivation of one gene does not disrupt the whole-body calcium homeostasis. Generation of double or triple knockouts of CaBP-9k plus other calcium-transport genes may shed further light on the active calcium transport mechanism. Taken together, a conclusive explanation indicates that the dynamic calcium transport pathways may be differentially controlled by various calcium transporter genes in the duodenum and kidney as shown in Fig. 1 .
